IRIS Accounts Production v23.3.1.45 06909765 director 1.6.22 31.5.23 31.5.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069097652022-05-31069097652023-05-31069097652022-06-012023-05-31069097652021-05-31069097652021-06-012022-05-31069097652022-05-3106909765ns10:Originalns15:EnglandWales2022-06-012023-05-3106909765ns14:PoundSterlingns10:Original2022-06-012023-05-3106909765ns10:Originalns10:Director12022-06-012023-05-3106909765ns10:Original2022-06-012023-05-3106909765ns10:Original2023-05-3106909765ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3106909765ns10:Originalns10:SmallEntities2022-06-012023-05-3106909765ns10:Originalns10:AuditExempt-NoAccountantsReport2022-06-012023-05-3106909765ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3106909765ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3106909765ns10:Originalns10:FullAccounts2022-06-012023-05-3106909765ns10:CompanySecretary1ns10:Original2022-06-012023-05-3106909765ns10:Originalns10:RegisteredOffice2022-06-012023-05-3106909765ns10:Original2022-05-3106909765ns10:Originalns5:CurrentFinancialInstruments2023-05-3106909765ns10:Originalns5:CurrentFinancialInstruments2022-05-3106909765ns10:Originalns5:Non-currentFinancialInstruments2023-05-3106909765ns10:Originalns5:Non-currentFinancialInstruments2022-05-3106909765ns5:ShareCapitalns10:Original2023-05-3106909765ns5:ShareCapitalns10:Original2022-05-3106909765ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3106909765ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3106909765ns10:Originalns5:PlantMachinery2022-06-012023-05-3106909765ns10:Original2021-06-012022-05-3106909765ns10:Originalns5:PlantMachinery2022-05-3106909765ns10:Originalns5:PlantMachinery2023-05-3106909765ns10:Originalns5:PlantMachinery2022-05-3106909765ns10:Originalns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-05-3106909765ns10:Originalns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-06-012023-05-3106909765ns10:Originalns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-05-3106909765ns10:Originalns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2022-05-3106909765ns10:Originalns5:CostValuation2022-05-3106909765ns10:Originalns5:AdditionsToInvestments2023-05-3106909765ns10:Originalns5:CostValuation2023-05-3106909765ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3106909765ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-3106909765ns10:Originalns5:CurrentFinancialInstruments2022-06-012023-05-3106909765ns10:Originalns5:Non-currentFinancialInstruments2022-06-012023-05-3106909765ns10:Originalns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3106909765ns10:Originalns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-3106909765ns5:BetweenOneFiveYearsns10:Originalns5:HirePurchaseContracts2023-05-3106909765ns5:BetweenOneFiveYearsns10:Originalns5:HirePurchaseContracts2022-05-3106909765ns10:Originalns5:HirePurchaseContracts2023-05-3106909765ns10:Originalns5:HirePurchaseContracts2022-05-3106909765ns10:Originalns5:WithinOneYear2023-05-3106909765ns10:Originalns5:WithinOneYear2022-05-3106909765ns5:BetweenOneFiveYearsns10:Original2023-05-3106909765ns5:BetweenOneFiveYearsns10:Original2022-05-3106909765ns10:Originalns5:MoreThanFiveYears2023-05-3106909765ns10:Originalns5:MoreThanFiveYears2022-05-3106909765ns10:Originalns5:AllPeriods2023-05-3106909765ns10:Originalns5:AllPeriods2022-05-31
REGISTERED NUMBER: 06909765 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 May 2023

for

Alimentary Innervations Limited

Alimentary Innervations Limited (Registered number: 06909765)

Contents of the Financial Statements
for the Year Ended 31 May 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Alimentary Innervations Limited

Company Information
for the Year Ended 31 May 2023







DIRECTOR: Dr A R Hobson





SECRETARY: Mrs S J Hobson





REGISTERED OFFICE: Lewis House
Great Chesterford Court
Great Chesterford
Essex
CB10 1PF





BUSINESS ADDRESS: 8 Dorset Square
LONDON
NW1 6PU





REGISTERED NUMBER: 06909765 (England and Wales)

Alimentary Innervations Limited (Registered number: 06909765)

Balance Sheet
31 May 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 753,888 603,809
Investments 6 2,191,657 150
2,945,545 603,959

CURRENT ASSETS
Debtors 7 855,931 723,683
Cash at bank and in hand 988,736 809,794
1,844,667 1,533,477
CREDITORS
Amounts falling due within one year 8 1,396,184 1,122,309
NET CURRENT ASSETS 448,483 411,168
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,394,028

1,015,127

CREDITORS
Amounts falling due after more than one
year

9

(2,000,759

)

(204,543

)

PROVISIONS FOR LIABILITIES (172,573 ) (138,676 )
NET ASSETS 1,220,696 671,908

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,220,596 671,808
SHAREHOLDERS' FUNDS 1,220,696 671,908

Alimentary Innervations Limited (Registered number: 06909765)

Balance Sheet - continued
31 May 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 November 2023 and were signed by:





Dr A R Hobson - Director


Alimentary Innervations Limited (Registered number: 06909765)

Notes to the Financial Statements
for the Year Ended 31 May 2023


1. STATUTORY INFORMATION

Alimentary Innervations Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Alimentary Innervations Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Significant judgements and estimates
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Investments in subsidiaries:
Deferred consideration due on investments in subsidiary undertakings have been discounted at a rate of 7.75% per annum.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 33% on reducing balance, 25% on reducing balance, 15% on reducing balance and over the remaining life of the lease

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Alimentary Innervations Limited (Registered number: 06909765)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


3. ACCOUNTING POLICIES - continued

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instruments.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes, in effect, a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Other financial instruments are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Alimentary Innervations Limited (Registered number: 06909765)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


3. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 19 (2022 - 14 ) .

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2022 1,197,493
Additions 358,015
Disposals (22,722 )
At 31 May 2023 1,532,786
DEPRECIATION
At 1 June 2022 593,684
Charge for year 188,622
Eliminated on disposal (3,408 )
At 31 May 2023 778,898
NET BOOK VALUE
At 31 May 2023 753,888
At 31 May 2022 603,809

Alimentary Innervations Limited (Registered number: 06909765)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 June 2022 237,156
Additions 40,298
Transfer to ownership (96,000 )
At 31 May 2023 181,454
DEPRECIATION
At 1 June 2022 126,538
Charge for year 17,206
Transfer to ownership (59,793 )
At 31 May 2023 83,951
NET BOOK VALUE
At 31 May 2023 97,503
At 31 May 2022 110,618

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 June 2022 150
Additions 2,191,507
At 31 May 2023 2,191,657
NET BOOK VALUE
At 31 May 2023 2,191,657
At 31 May 2022 150

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 620,525 495,543
Amounts owed by group undertakings 13,384 43,464
Other debtors 222,022 184,676
855,931 723,683

Alimentary Innervations Limited (Registered number: 06909765)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 301,250 88,312
Hire purchase contracts (see note 10) 30,635 33,676
Trade creditors 496,742 381,915
Amounts owed to group undertakings - 710
Taxation and social security 108,962 158,336
Other creditors 458,595 459,360
1,396,184 1,122,309

Other creditors in the above table consist of accrued expenses of £341,776 (2022 - £395,736), director's loans of £114 (2022 - £54,942), deferred consideration of £107,264 (2022 - £nil), pension creditors of £4,125 (2022 - £3,081), and credit card balances of £5,316 (2022 - £5,601).

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 1,856,577 179,221
Hire purchase contracts (see note 10) 30,007 25,322
Other creditors 114,175 -
2,000,759 204,543

Other creditors in the above table consist entirely of deferred consideration.

10. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2023 2022
£    £   
Net obligations repayable:
Within one year 30,635 33,676
Between one and five years 30,007 25,322
60,642 58,998

Non-cancellable operating leases
2023 2022
£    £   
Within one year 274,242 229,471
Between one and five years 629,739 602,635
In more than five years 495,781 619,726
1,399,762 1,451,832

Alimentary Innervations Limited (Registered number: 06909765)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2023


11. SECURED DEBTS

The following secured debts are included within creditors:

2023 2022
£    £   
Bank loans 2,157,857 85,714

On 16 September 2022, Triple Point Advancr Leasing plc placed a fixed and floating charge over the undertaking and all property, including all future and present freehold and leasehold property, all present and future intellectual property rights.